期刊文献+

青蒿琥酯逆转食管癌Eca109/ADM细胞对多柔比星的耐药 被引量:5

Role of artesunate in resistance-reversal of esophageal cancer Eca109/ADM cells to doxorubicin
下载PDF
导出
摘要 目的:研究青蒿琥酯(artesunate,Art)逆转食管癌细胞Eca109/ADM对多柔比星(doxorubicin,ADM)的耐药作用及其机制。方法:实验分为生理盐水(normal saline,NS)对照组(NS组)、Art组(0.1μmol/L)、ADM组(0.2μg/ml)和Art+ADM联合组。Art、ADM、Art+ADM作用Eca109/ADM细胞48 h后,流式细胞术检测细胞凋亡率、细胞内ADM的含量及细胞中三磷酸腺苷结合转运蛋白G超家族成员2(ATP-binding cassette transporter G2,ABCG2)蛋白的表达量,Western blotting检测细胞中ABCG2蛋白表达水平。结果:Art+ADM作用Eca109/ADM细胞48 h后,细胞的凋亡率[(12.89±0.87)%]显著高于Art组[(1.58±0.12)%]、ADM组[(6.55±0.90)%]及NS组[(1.44±0.10)%](P<0.05),Art可提高Eca109/ADM细胞对ADM的敏感性。流式细胞术检测结果显示,Art+ADM组Eca109/ADM细胞中ABCG2蛋白表达量(644.60±3.21)显著低于ADM组(659.15±4.59)及NS组(658.14±6.88)(P<0.05),但与Art组(644.31±3.96)相比无显著差异(P>0.05)。Western blotting检测结果与流式细胞术结果一致,Art组Eca109/ADM细胞中ABCG2蛋白的表达水平为(0.70±0.02),与对照组的(0.80±0.03)相比显著降低(P<0.05),Art+ADM组的ABCG2蛋白(0.71±0.04)与单独应用ADM组的ABCG2蛋白(0.81±0.05)相比,ABCG2蛋白表达水平显著降低(P<0.05)。Art+ADM组Eca109/ADM细胞内ADM的含量(848.02±5.04)显著高于单独应用Art组(763.29±4.02)、ADM组(800.25±3.84)及NS组(763.88±2.03)(P<0.01)。结论:Art可以降低食管癌Eca109/ADM细胞内ABCG2蛋白表达,增加ADM的含量,逆转肿瘤细胞对ADM的耐药。 Objective: To explore the role of artesunate(Art) in resistance-reversal of Eca109/ADM cells and the related mechanism.Methods:The present study was divided into 4 groups: normal saline(NS) control group,Art(0.1 μmol/L) group,ADM(0.2 μg/ml) group,and Art(0.1 μmol/L)+ADM(0.2 μg/ml) group.The apoptosis rate,ADM content and ABCG2(ATP-binding cassette transporter G2) protein expression in Eca109/ADM cells were detected by flow cytometry 48 h after treated with Art,ADM,and Art+ADM.ABCG2 protein expression in Eca109/ADM cells was further examined by Western blotting analysis.Results:The apoptosis rate of Eca109/ADM cells in Art+ADM group was(12.89±0.87)%,being significantly higher than that in the Art group(1.58±0.12)%,ADM group(6.55±0.90)% and NS group(1.44±0.10)%(P〈0.05).Art increased the sensitivity of Eca109/ADM cells to ADM.Flow cytometry results showed that the ABCG2 protein expression in Eca109/ADM cells of Art+ADM group(644.60±3.21) was significantly lower than that in ADM group(659.15±4.59) and NS group(658.14±6.88)(P〈0.05),but was similar to that in Art group(644.31±3.96)(P〉0.05).Western blotting analysis results were consistent with those detected by flow cytometry.The ABCG2 protein expression of Eca109/ADM cells in Art group(0.70±0.02) was significantly decreased compared with NS group(0.80±0.03)(P〈0.05),and that in Art+ADM group(0.71±0.04) was also decreased compared with ADM group(0.81±0.05)(P〈0.05).The ADM content of Eca109/ADM cells in Art+ADM group was significantly higher than those in Art,ADM and NS groups(848.02±5.04 vs 763.29±4.02,800.25±3.84,763.88±2.03;P〈0.01).Conclusion: Art can decrease ABCG2 protein expression and increase ADM content in Eca109/ADM cells,and it can also reverse the drug resistance of Eca109/ADM cells.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2011年第2期155-159,共5页 Chinese Journal of Cancer Biotherapy
基金 河北省自然科学基金资助项目(No.C2007001060) 河北省普通高等学校强势特色学科肿瘤学基金资助项目(No.[2005]52)~~
关键词 青蒿琥酯 多柔比星 耐药逆转 三磷酸腺苷结合转运蛋白G超家族成员2(ABCG2) artesunate doxorubicin resistance-reversal ATP-binding cassette transporter G2 (ABCG2)
  • 相关文献

参考文献24

  • 1Chao KC, Chang CC, Yen MS, et ah Anti-tumor activity of histone deacetylase inhlbitors and the effect on ATP-binding cassette in ovarian carcinoma cells [ J]. Eur J Gynaecol Oncol, 2010, 31 (4) : 402-410.
  • 2Hagmann W, Jesnowski R, Lohr JM. Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells [ J]. Neoplasia, 2010, 12 (9) : 740- 747.
  • 3Kudo I, Esumi M, Kida A, et al. p53 mutation, but not in vitro predictor genes of therapeutic efficacy of cisplatin, is clinically relevant in comparing partial and complete responder eases of maxillary squamons cell carcinoma [ J]. Oncol Rep, 2010, 24 (4) : 851-856.
  • 4Li S, Shi H, Ji F, et al. The human lung cancer drug resistancerelated gene BC006151 regulates ehemosensitivity in H446/CDDP cells [J].Biol Pharm Bull, 2010, 33(8) : 1285-1290.
  • 5Tanaka T, Bai T, Toujima S. Establishment and characterization of monoclonal 5-fluorouracil-resistant cell lines derived from human endometrial adenocarcinoma [ J ]. Int J Oncol, 2010, 37 ( 3 ) : 731-736.
  • 6Landriscina M, Laudiero G, Maddalena F, et al. Mitochondrial chaperone Trapl and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents [J]. CancerRes, 2010, 70( 16): 6577-6586.
  • 7Zhang Z, Deng X, Ren X, et al. Expression of mutant p53 and of the multidrug resistant proteins P-glycoprotein and glutathione S- transferase-pi correlated in colorectal adenocarcinoma [ J]. Scand J Gastroenterol, 2010, 45 (7/8) : 925-934.
  • 8Yoo BK, Chen D, Su ZZ, et al. Molecular mechanism of chemoresistanee by astroeyte elevated gene-1 [J ]. Cancer Res, 2010, 70(8) : 3249-3258.
  • 9Zutz A, Gompf S, Schagger H, et al. Mitochondrial ABC proteins in heahh and disease [J]. Biochim Biophys Acta, 2009, 1787 (6) : 681-690.
  • 10Gottesman MM, Fojo T, Bates SE. Muhidrug resistance in cancer: Role of ATP dependent transporters [ J ]. Nat Rev Cancer, 2002, 2(1): 48-58.

二级参考文献69

  • 1李哲,袁守军,聂丽平,田增月,徐兰平,韩昌明.青蒿琥酯诱导肿瘤细胞凋亡与抑制存活蛋白表达有关[J].中国临床药理学与治疗学,2004,9(6):607-611. 被引量:41
  • 2赵君宁,何一然,张振玉,孙士其,王书奎.青蒿琥酯对人胃癌细胞增殖及凋亡的影响[J].中国癌症杂志,2005,15(4):347-350. 被引量:14
  • 3DOYLE LA,YANG W, ABRUZZO LV,et al. A muhidrug resistance transporter from human MCF-7 breast cancer cells [J]. Proc Natl Acad Sci USA, 1998,95(26) : 15665-15670.
  • 4BATRS SE, ROBEY R, MIYAKE K, et al. The role of half-transporters in multidrug resistance [J]. J Bioenerg Biomembr,2001,33 (6) : 503- 511.
  • 5KAWABATA S, OKA M, SODA H, et al. Expression and functional analyses of breast cancer resistance protein in lung cancer[J]. Clin Cancer Res,2003,9(8) :3052.
  • 6STEINBACH D, SELL W, VOIGTO A, et al. BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia [J]. Leukemia,2002,16 (8): 1443 - 1447.
  • 7ZHOU S,SCHUETZ JD,BUNTING KD,et al. The ABC transporter Bcrpl /ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype [J].Nat Med, 2001,7(9) : 1028-1034.
  • 8DONNENBERG VS,DONNENBERG AD. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis [J]. J Clin Phamacol, 2005,45 (8) : 872-877.
  • 9PATRAWAKA L, CALHOUN T, SCHNEIDER-BROUSSARD R, et al. Side population is enriched in tumorigenic,stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic [J]. Cancer Res, 2005,65 (14) : 6207-6220.
  • 10HIRSHMANN-JAX C,FOSTER AE ,WULF GG,et al. A distinct " side population" of cells with high drug efflux capacity in human tumor cells[J] . PNAS,2004,101(39) : 14228-14233.

共引文献19

同被引文献69

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部